Martek Biosciences has reached a settlement with Capsugel France that will see the supplement maker purchase all its algal DHA exclusively from Martek.
Go deeper with GlobalData
The news draws to a close Martek’s patent infringement action, which was filed in the High Court of Strasbourg, France, last year.
Additionally, Martek and Capsugel will jointly develop a product containing Martek’s algal DHA in Capsugel’s proprietary Licaps liquid-filled hard capsules, the companies revealed.
This settlement agreement between Martek and Capsugel does not include Martek’s action against Lonza, which continues, Martek said.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData
